Search for dissertations about: "dyslipidemia"
Showing result 6 - 10 of 88 swedish dissertations containing the word dyslipidemia.
-
6. Role of Proneurotensin in Cardiometabolic Diseases
Abstract : The burden of cardiometabolic diseases is increasing worldwide. Early detection of high-risk individuals is essential for appropriate diagnosis, better treatment outcomes, quality of life and lower health related costs. READ MORE
-
7. Cardiovascular Risk Genes in Prevention and Treatment Response
Abstract : GENERAL AIM: To investigate how common single-nucleotide-polymorphisms (SNPs) that associate with cardiovascular disease (CVD) could be used in prevention and treatment of CVD. SUBJECTS: Subjects from the population-based Malmö-Diet-and-Cancer-(MDC)-Study (n=30447) and hypertensives from the Nordic-Diltiazem-(NORDIL)-Study (n=10881). READ MORE
-
8. Nutritional status, body composition and diet in patients with rheumatoid arthritis
Abstract : Rheumatoid arthritis (RA) is a chronic inflammatory disease with higher mortality rate than in the general population, which is largely attributed to cardiovascular disease (CVD). Another consequence of the inflammatory process is change in body composition with decreased muscle mass and increased fat mass. READ MORE
-
9. Assembly and Secretion of Atherogenic Lipoproteins
Abstract : The classical dyslipidemia seen in patients with type 2 diabetes is characterized by elevated serum triglycerides (TG), low levels of high-density lipoprotein cholesterol and the appearance of small, dense low-density lipoproteins (LDL). It is now recognized that the different components of diabetic dyslipidemia are not isolated abnormalities but are closely linked to each other metabolically, and are initiated by the hepatic overproduction of large triglyceride-rich very low-density lipoproteins (VLDL1). READ MORE
-
10. Metabolic Disturbances in Relation to Serum Calcium and Primary Hyperparathyroidism
Abstract : Primary hyperparathyroidism (pHPT), characterized by elevated serum levels of calcium and parathyroid hormone (PTH), is associated with a number of metabolic derangements causing secondary manifestations. These include osteoporosis and increased risk of fractures, but also risk factors for cardiovascular morbidity and mortality. READ MORE